This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MESOTHELIOMA_EXALLC for full statistics.
Mesothelioma
C3_MESOTHELIOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
451 |
4. Check minimum number of eventsNone |
451 |
5. Include endpointsNone |
451 |
6. Filter based on genotype QC (FinnGen only) |
451 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C45-C49
- Name in latin
- Mesothelioma
Similar endpoints
↥List of similar endpoints to
Mesothelioma
based on the number of shared cases.
Similar with more cases:
- Mesothelioma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 451 | 117 | 334 |
| Unadjusted period prevalence (%) | 0.12 | 0.04 | 0.15 |
| Median age at first event (years) | 70.24 | 64.97 | 72.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 404
- Matched controls
- 4041
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
323.0
299
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
41.8
167.7
216
108
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
135.2
122
*
130
Kela drug reimbursment
Malignant tumour
15.5
111.3
210
264
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
1303.1
106.3
99
*
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
103.7
95
*
H02AB02
ATC
dexamethasone; systemic
14.5
95.1
179
210
J94.8
ICD-10 Finland
Other specified pleural conditions
47.3
78.2
95
26
A03FA01
ATC
metoclopramide; systemic, rectal
7.2
65.8
202
492
N02AA05
ATC
oxycodone; systemic
7.2
64.4
195
463
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
25.0
62.3
89
45
C45.9
ICD-10 Finland
Mesothelioma, unspecified
+∞
59.9
56
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
15.5
58.2
100
84
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
57.7
54
*
Z51.5
ICD-10 Finland
Palliative care
9.8
55.4
122
170
A04AA01
ATC
ondansetron; systemic, rectal
11.9
52.5
102
111
TGA30
NOMESCO Finland
Thoracocentesis
49.1
49.1
59
14
GAC00
NOMESCO Finland
Biopsy of pleura
86.5
48.3
53
7
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
17.3
41.1
66
45
1BA04
NOMESCO Finland
NA
439.0
40.9
40
*
J94.9
ICD-10 Finland
Pleural condition, unspecified
98.5
33.3
36
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
13.4
33.1
59
51
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
32.7
31
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.9
30.0
80
140
JN4BD
NOMESCO Finland
Extensive body CT
4.9
29.9
111
290
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.0
29.1
69
101
L01CA04
ATC
vinorelbine; systemic
33.8
28.7
37
12
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.7
28.5
111
303
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
39.7
26.6
33
9
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.5
26.5
65
100
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
72.0
24.1
27
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
254.3
23.9
24
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
17.6
21.8
34
21
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
21.5
85
230
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
220.8
20.8
21
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
20.6
241
1419
A04AA55
ATC
palonosetron, combinations; systemic
18.3
19.0
29
17
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
18.9
120
473
R84
ICPC
Malignant neoplasm bronchus/lung
40.5
18.7
23
6
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
17.8
17
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.1
17.3
48
87
WX600
NOMESCO Finland
Single shot through catheter
16.9
17.3
27
17
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.3
16.6
45
79
WF004
NOMESCO Finland
Palliative radiotherapy
9.4
16.0
33
38
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
15.6
77
250
A06AH03
ATC
naloxegol; oral
13.8
15.4
26
20
GD1AD
NOMESCO Finland
Thorax CT examination
5.6
15.2
45
88
B03BA03
ATC
hydroxocobalamin; parenteral
4.0
15.1
64
182
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
14.7
14
*
GAC43
NOMESCO Finland
Total decortication of pleura
+∞
14.7
14
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
+∞
14.7
14
*
GAA31
NOMESCO Finland
Thoracoscopy
37.5
14.6
18
5
J01MA12
ATC
levofloxacin; systemic
2.7
14.5
119
543
A04AA02
ATC
granisetron; systemic, transdermal
4.6
13.7
48
114
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
77.8
13.7
15
*
C45
ICD-10 Finland
Mesothelioma
+∞
13.6
13
*
J01MA14
ATC
moxifloxacin; systemic
3.4
13.2
67
221
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
11.5
13.2
24
22
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
10.6
12.7
24
24
R82
ICPC
Pleurisy/pleural effusion
+∞
12.6
12
*
C45.7
ICD-10 Finland
Mesothelioma of other sites
+∞
12.6
12
*
ZX120
NOMESCO Finland
Intravenous
3.4
12.5
64
213
N02AA01
ATC
morphine; systemic, rectal
9.1
12.2
25
29
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.1
11.8
37
78
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.1
11.7
47
127
GAC30
NOMESCO Finland
Artificial pneumothorax
+∞
11.5
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.5
11
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
11.4
45
120
JN4AD
NOMESCO Finland
Body CT examination
3.4
11.4
57
186
WZC30
NOMESCO Finland
Teaching
2.9
11.3
75
298
JAL30
NOMESCO Finland
Omentectomy
28.9
10.8
14
5
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.6
10.5
49
151
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
112.8
10.5
11
*
Z57.2
ICD-10 Finland
Occupational exposure to dust
33.5
10.4
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
10.1
46
140
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
30.8
9.4
12
*
TK800
NOMESCO Finland
Hemodialysis
5.4
9.3
27
53
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
9.2
149
906
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
9.1
102
532
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.0
8.7
23
40
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.1
8.4
18
23
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
91.9
8.4
9
*
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
6.5
8.4
21
34
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.1
8.4
22
38
1638X
ICD-9 Finland
Malignant neoplasm of pleura, Other specified sites of pleura
+∞
8.4
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.4
8
*
Z2446
NOMESCO Finland
Social worker
3.5
8.3
38
116
R06.0
ICD-10 Finland
Dyspnoea
2.0
8.2
121
704
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
17.6
8.1
12
7
R85
ICPC
Malignant neopl respiratory other
22.5
8.1
11
5
N03AX16
ATC
pregabalin; oral
2.1
7.7
99
543
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
18.8
7.6
11
6
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
81.5
7.4
8
*
SPAT1062
SPAT
Lung clearance therapy
81.5
7.4
8
*
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
7.3
7
*
1580A
ICD-9 Finland
Malignant neoplasm of retroperitoneum and peritoneum, Retroperitoneum
+∞
7.3
7
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
7.3
7
*
H02AB06
ATC
prednisolone; systemic
1.8
7.3
193
1369
A79
ICPC
Malignancy NOS
8.1
7.2
15
19
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
20.4
7.2
10
5
J86.9
ICD-10 Finland
Pyothorax without fistula
7.2
7.1
16
23
A04AD12
ATC
aprepitant; systemic
6.5
7.0
17
27
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
7.7
7.0
15
20
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
6.9
113
681
XX1XW
NOMESCO Finland
Extensive written report from radiologist
6.3
6.8
17
28
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
40.7
6.8
8
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
70.9
6.4
7
*
6101
FHL
Exploratory laparotomy, includes possible biopases
14.6
6.4
10
7
A04AA03
ATC
tropisetron; systemic
18.4
6.3
9
5
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
6.3
72
1179
GAC20
NOMESCO Finland
Excision or destruction of lesion of pleura
+∞
6.3
6
*
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
12.8
6.1
10
8
R4110
NOMESCO Finland
Physiotherapy
1.9
6.1
108
662
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003434) Protein [Mass/volume] in Pleural fluid
155
77
30.15
213.05
1.9
1.4
g/l
40.6
30.4
8.22
148
70
(40768806) Pleura Pathology biopsy report
146
66
32.23
207.88
2.3
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
143
63
32.77
205.45
2.0
1.3
e6/l
1669.8
1920.8
0.20
118
44
(3028308) Erythrocytes [#/volume] in Pleural fluid
139
57
34.80
204.85
2.0
1.3
e6/l
41882.1
151688.9
0.85
102
34
(3012441) Differential panel - Pleural fluid
134
58
32.45
193.28
1.9
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
99
50
25.09
132.70
2.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
107
105
13.05
99.94
2.1
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
127
169
10.07
95.04
2.2
3.3
—
—
—
0
0
(3035880) pH of Pleural fluid
61
32
21.89
79.37
1.6
1.2
—
—
—
0
0
(4035726)
154
329
6.59
73.74
1.7
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
172
593
4.07
43.46
2.6
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
70
113
7.15
42.90
1.5
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
166
615
3.69
36.87
5.4
3.7
mmol/l
0.8
0.8
3.62
158
574
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
144
498
3.78
35.27
3.1
4.0
u/l
208.7
249.1
6.41
144
469
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
136
458
3.82
34.57
2.3
4.7
ug/l
2.2
40.1
1.44
107
390
(42870588) Differential panel, method unspecified - Blood
209
1174
2.45
19.11
6.7
5.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
30
51
6.23
17.20
8.3
5.7
mg/l
10.9
11.9
0.59
30
46
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
224
3138
0.43
17.00
5.6
6.7
mmol/mol
41.0
41.2
0.16
196
2842
(3023368) Bacteria identified in Blood by Culture
204
1253
2.15
13.88
6.1
4.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
250
3278
0.47
13.70
3.8
5.4
mmol/l
2.5
2.5
0.14
207
2927
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
238
3163
0.48
13.26
3.7
4.8
mmol/l
1.4
1.4
0.12
201
2810
(3035637) Corticotropin [Mass/volume] in Plasma
20
29
7.17
13.24
2.0
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
242
3194
0.48
13.12
3.6
4.8
mmol/l
4.3
4.3
0.03
203
2872
(3002030) Lymphocytes/100 leukocytes in Blood
241
1605
2.08
12.95
7.4
5.9
%
20.5
25.5
9.40
236
1489
(3033658) Prothrombin time (PT) actual/Normal
158
903
2.15
12.71
8.3
4.2
%
84.7
81.8
0.88
151
885
(3019069) Monocytes/100 leukocytes in Blood
238
1588
2.06
12.61
7.5
6.1
%
9.6
9.1
1.68
232
1481
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
89
4.05
11.87
1.2
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
170
3.18
11.83
2.8
2.4
u/ml
0.3
0.4
0.76
28
91
(3001604) Monocytes [#/volume] in Blood
246
1691
2.00
11.67
6.9
5.4
e9/l
0.7
0.6
6.43
209
1451
(3042631) Mycobacterium sp identified in Specimen
29
68
4.49
11.66
2.4
2.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
90
420
2.43
11.64
1.5
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
277
1987
2.02
11.62
16.5
9.4
e9/l
5.2
4.3
1.98
244
1747
(3006315) Basophils [#/volume] in Blood
246
1699
1.99
11.43
6.9
5.4
e9/l
0.0
0.0
0.34
211
1470
(4281824)
19
31
6.35
11.28
1.4
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
247
1724
1.96
10.96
7.0
5.5
e9/l
1.6
1.9
3.05
213
1511
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
238
3063
0.53
9.94
3.3
4.3
mmol/l
1.2
1.2
0.48
195
2704
(3013115) Eosinophils [#/volume] in Blood
246
1756
1.88
9.79
7.4
5.6
e9/l
0.2
0.2
0.36
214
1539
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
265
1960
1.85
9.19
11.9
6.9
umol/l
9.8
12.2
2.21
260
1848
(40758558) Short blood count panel - Blood
138
832
1.95
9.09
12.4
6.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
262
3245
0.54
9.00
4.7
5.1
mmol/l
6.2
6.1
0.30
228
2872
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
281
2.44
8.90
4.4
4.2
mmol/l
2.9
2.0
1.28
57
217
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
257
1901
1.82
8.73
9.5
7.4
mmol/l
1.2
1.2
0.15
228
1587
(3032080) INR in Blood by Coagulation assay
240
1742
1.81
8.65
6.0
11.6
inr
1.1
1.4
7.65
40
472
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
242
1763
1.80
8.60
8.0
6.6
mmol/l
1.2
1.2
0.21
230
1567
(3009343) pH of Capillary blood
65
299
2.37
8.57
4.4
4.1
ph
7.4
7.4
—
6
28
(3022313) Gas panel - Capillary blood
53
224
2.55
8.38
4.5
4.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
229
1687
1.73
7.44
7.7
5.1
g/l
30.5
34.5
14.81
222
1565
(40768804) Tissue Pathology biopsy report
191
1339
1.74
7.41
2.8
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
141
906
1.81
7.38
3.3
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
166
1120
1.76
7.36
5.0
4.4
ph
7.4
7.4
0.43
26
226
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
61
3.74
7.11
1.1
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
242
2994
0.59
7.08
5.2
4.4
mu/l
2.1
2.0
0.36
218
2619
(3011544) Albumin [Mass/volume] in Pleural fluid
11
8
14.05
6.92
1.2
1.0
g/l
26.2
18.3
—
11
8
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
33
4.67
6.50
1.5
1.8
u/l
2.6
11503.0
—
5
8
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
38
4.33
6.33
1.4
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
120
768
1.77
6.23
5.9
3.5
mmol/l
2.5
2.5
7.36
108
677
(3012516) Albumin [Mass/volume] in Urine
69
1174
0.51
6.15
2.8
3.3
mg/l
26.4
241.9
1.72
44
775
(3020682) Albumin/Creatinine [Ratio] in Urine
77
1249
0.54
5.81
3.8
4.1
mg/mmol
6.5
10.3
0.77
45
802
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
71
3.21
5.69
1.4
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
168
1202
1.63
5.68
3.6
2.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
72
1185
0.53
5.68
2.8
3.2
mmol/l
8.9
7.4
1.62
55
949
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
156
2082
0.62
5.50
4.3
5.7
ug/l
2.6
3.8
1.05
126
1812
(3015377) Calcium [Moles/volume] in Serum or Plasma
175
1274
1.61
5.47
6.3
3.7
mmol/l
2.3
2.3
0.04
158
1091
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
116
1643
0.60
5.13
1.8
2.1
pmol/l
95.5
92.1
0.32
69
883
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
27
4.54
5.06
1.6
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
119
1667
0.61
4.99
3.5
4.8
%
22.7
21.6
0.38
61
887
(1616796) Gas panel - Central venous blood
24
89
2.79
4.92
3.5
4.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
47
238
2.09
4.91
11.9
10.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
63
357
1.89
4.80
1.4
1.3
titre
420.0
366.6
0.17
12
73
(3000963) Hemoglobin [Mass/volume] in Blood
320
3596
0.62
4.77
46.8
26.5
g/l
124.1
133.8
19.44
310
3521
(3010813) Leukocytes [#/volume] in Blood
320
3595
0.62
4.74
46.7
26.4
e9/l
8.3
7.0
2.98
305
3468
(3035941) MCH [Entitic mass]
320
3595
0.62
4.74
46.4
26.2
pg
29.5
30.5
15.68
310
3522
(3026361) Erythrocytes [#/volume] in Blood
320
3595
0.62
4.74
46.6
26.3
e12/l
4.3
4.4
4.96
304
3466
(3024731) MCV [Entitic volume]
320
3594
0.62
4.72
46.5
26.3
fl
90.2
91.9
7.19
310
3522
(3007461) Platelets [#/volume] in Blood
320
3594
0.62
4.72
46.6
26.3
e9/l
294.6
233.0
24.75
304
3484
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
55
3.17
4.40
1.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
95
2.61
4.37
1.3
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
96
2.58
4.29
1.3
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
246
1.97
4.16
1.8
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
108
741
1.60
4.15
1.8
1.7
mg/l
1.8
1.6
0.33
88
592
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
311
3488
0.65
4.11
18.3
11.6
u/l
24.4
25.0
0.30
301
3334
(3000991) Gas panel - Venous blood
60
353
1.81
4.06
11.7
9.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
315
3516
0.65
3.94
35.7
21.7
mmol/l
4.0
4.0
0.03
304
3417
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
144
1067
1.51
3.91
4.1
3.4
u/l
34.0
34.2
0.02
135
1012
(1761868) Lipid panel - Serum or Plasma
58
926
0.57
3.90
2.9
3.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
39
3.40
3.79
1.6
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
315
3508
0.66
3.78
35.6
21.6
mmol/l
138.3
139.6
9.86
305
3408
(3021960) Folate [Moles/volume] in Serum or Plasma
68
1030
0.60
3.71
1.5
1.6
nmol/l
22.5
19.4
0.88
63
854
(40761511) CBC panel - Blood by Automated count
303
3394
0.67
3.66
31.0
17.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
194
2354
0.69
3.61
4.4
3.5
pmol/l
14.9
15.0
0.03
176
2051
(3009261) Glucose [Presence] in Urine by Test strip
131
1707
0.67
3.56
3.8
4.1
estimate
0.0
0.0
0.00
32
318
(3052851) Hemolysis interference index of Serum or Plasma
27
125
2.23
3.55
4.9
3.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
80
534
1.61
3.42
9.0
7.7
mmol/l
1.8
1.3
0.76
70
412
(3033799) Differential panel - Peritoneal fluid
8
14
5.80
3.35
1.3
2.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
8
14
5.80
3.35
2.4
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
103
732
1.53
3.35
2.0
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
288
1.79
3.34
1.7
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
131
1679
0.69
3.16
3.8
4.1
estimate
0.0
0.0
0.00
32
334
(3021601) Nitrite [Presence] in Urine by Test strip
131
1677
0.69
3.13
5.0
5.4
estimate
0.0
0.0
0.00
33
334
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
148
1146
1.43
3.11
3.7
2.5
u/l
53.6
56.8
0.52
139
1058
(3003458) Phosphate [Moles/volume] in Serum or Plasma
78
530
1.57
3.09
5.5
6.1
mmol/l
1.0
1.0
0.26
73
482
(36304419) Bacteria [Presence] in Urine
136
1040
1.44
3.05
2.6
3.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
12
5.90
3.03
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
45
266
1.77
3.02
1.4
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
113
838
1.46
2.96
2.5
3.0
mosm/kgh2o
543.5
579.9
1.10
100
709
(3022145) Colonoscopy Study observation
20
410
0.46
2.96
1.4
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
99
1321
0.68
2.91
2.1
2.2
nmol/l
74.6
77.6
0.47
84
1130
(40767503) Oxygen content in Capillary blood by calculation
20
89
2.31
2.91
2.3
2.5
%
15.3
15.9
—
10
43
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
61
898
0.63
2.88
1.7
1.8
pmol/l
497.7
7830098.5
0.50
52
728
(3019150) Specific gravity of Urine by Refractometry
49
758
0.60
2.85
4.1
4.7
kg/l
1.0
1.0
—
6
124
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
47
2.82
2.84
2.1
4.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
142
1115
1.40
2.70
2.6
3.4
e6/l
0.9
0.6
0.50
112
865
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
280
3121
0.73
2.64
29.9
16.9
ml/min/173m2
76.7
72.9
2.52
253
2610
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
309
0.44
2.53
1.9
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
101
1314
0.70
2.52
4.1
4.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
105
2.05
2.34
1.5
1.5
iu/ml
0.0
0.1
—
7
24
(3017446) Testosterone [Moles/volume] in Serum or Plasma
16
325
0.47
2.33
1.9
2.2
nmol/l
10.2
11.9
0.40
16
273
(3021589) Normoblasts [#/volume] in Blood
179
1487
1.34
2.33
13.4
10.4
e9/l
0.0
0.0
0.43
134
1220
(4062490)
9
28
3.26
2.32
1.6
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
200
1693
1.33
2.27
5.2
4.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
62
0.00
2.24
0.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
67
2.28
2.20
1.5
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
16
74
2.20
2.17
1.6
1.3
mmol/l
87.4
61.1
—
9
64
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
290
0.47
2.17
6.6
2.9
ml/min/173m2
67.7
58.7
—
7
123
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
19
3.72
2.16
1.7
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
19
3.72
2.16
1.7
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
25
3.24
2.10
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
31
2.94
2.08
7.1
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
56
2.36
2.06
1.5
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
26
3.11
2.02
1.8
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
66
476
1.45
1.99
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
84
2.06
1.98
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
84
2.06
1.98
1.6
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
252
0.46
1.94
2.1
3.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
39
2.60
1.93
1.1
1.9
—
—
—
0
0
(3020891) Body temperature
8
182
0.43
1.85
2.4
4.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
147
1220
1.30
1.85
2.7
3.6
e6/l
49.1
132.6
0.83
118
972
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
68
501
1.42
1.84
1.9
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
31
192
1.66
1.83
3.9
4.6
mmol/l
25.1
23.7
1.02
31
176
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
171
1452
1.29
1.80
2.6
3.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
117
1422
0.76
1.78
2.7
2.8
ug/l
427.1
166.3
2.38
110
1279
(3021901) Oxygen saturation in Capillary blood
17
88
1.97
1.77
2.6
3.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
74
2.06
1.77
1.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
275
1.54
1.76
2.0
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
74
560
1.38
1.72
11.0
7.5
mmol/l
103.7
104.1
0.37
74
547
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
89
1.95
1.72
2.1
2.2
g/l
127.1
127.9
0.03
11
62
(3013826) Glucose [Moles/volume] in Serum or Plasma
250
2234
1.27
1.71
8.1
5.4
mmol/l
6.9
6.9
0.09
241
2116
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
98
777
1.33
1.70
5.1
4.0
ng/l
96.9
313.3
1.94
84
663
(3022806) Fractional oxyhemoglobin in Capillary blood
12
56
2.17
1.62
1.8
1.7
%
87.9
89.4
0.65
12
56
(3029937) Albumin [Presence] in Urine by Test strip
76
970
0.74
1.61
4.3
4.4
estimate
0.0
0.0
0.00
31
313
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
64
2.06
1.55
1.5
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
643
1.34
1.53
2.3
3.3
e6/l
1.9
1.3
0.44
45
386
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
58
2.10
1.50
4.0
2.8
e9/l
4.1
4.6
0.46
12
58
(3044889) 12 lead EKG panel
220
2444
0.81
1.50
3.9
4.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
61
795
0.73
1.48
3.4
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
504
1.36
1.47
1.8
1.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
39
2.33
1.43
1.7
2.6
nmol/l
2.3
7.9
—
9
39
(3013707) Erythrocyte sedimentation rate by Westergren method
231
2546
0.81
1.43
4.2
4.2
mm/h
26.0
14.2
7.27
220
2296
(3045414) Leukocytes [Presence] in Urine
6
137
0.43
1.42
1.7
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
40
554
0.69
1.40
1.4
1.4
g/l
2.1
2.8
0.71
21
319
(3041096) Erythrocytes [Presence] in Urine by Automated
72
906
0.76
1.38
3.9
3.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
82
1.86
1.37
1.3
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
17
2.96
1.36
1.6
3.2
nmol/l
74.8
72.5
—
5
17
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
99
1191
0.78
1.34
3.0
3.3
ug/l
0.8
0.8
0.04
75
849
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
61
1.99
1.34
4.2
3.3
%
58.8
60.1
0.10
12
61
(3010421) pH of Blood
19
113
1.71
1.34
4.8
4.7
ph
7.4
7.4
0.75
19
94
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
121
1.68
1.33
1.3
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
43
2.11
1.31
1.2
3.7
u/ml
35.2
33.4
—
9
43
(40761535) Cells panel - Urine sediment
23
351
0.64
1.31
2.3
3.8
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
24
2.52
1.31
3.3
2.0
mmol/l
8.0
7.4
—
6
16
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
134
0.44
1.30
1.3
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
18
2.80
1.29
1.6
4.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
48
2.11
1.28
6.8
3.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
35
2.31
1.27
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
118
0.42
1.26
1.2
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
190
1.51
1.19
2.4
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
313
3318
0.81
1.19
37.3
18.1
mg/l
49.2
28.0
13.85
294
2757
(4010399)
35
249
1.44
1.19
1.2
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
96
1142
0.80
1.17
3.8
3.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
33
0.00
1.16
0.0
3.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
100
843
1.24
1.08
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
242
2616
0.84
1.08
40.3
21.6
%
14.6
13.9
7.18
234
2562
(3004588) Protein electrophoresis panel - Serum or Plasma
19
288
0.64
1.07
1.1
2.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
84
1004
0.80
1.07
2.6
3.0
umol/l
4145.4
8145.7
0.46
69
845
(3003338) MCHC [Mass/volume]
238
2573
0.84
1.05
40.7
24.2
g/l
326.3
332.1
13.41
232
2554
(3019225) pH of Specimen
52
406
1.32
1.03
6.3
4.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
22
2.29
1.03
2.2
2.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
34
2.08
1.03
2.9
2.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
30
215
1.42
1.00
3.1
2.9
e9/l
5.3
4.0
1.02
21
153
(3043409) Potassium [Moles/volume] in Arterial blood
9
157
0.56
1.00
1.6
3.8
mmol/l
3.9
4.0
—
9
145
(3018095) Leukocytes [#/volume] in Urine
154
1366
1.19
1.00
3.2
4.0
e6/l
94.4
128.1
0.22
121
1034
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
23
2.19
0.98
1.6
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
23
2.19
0.98
1.6
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
72
867
0.80
0.98
1.7
1.8
nmol/l
1098.3
1180.2
0.32
46
642
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.1
—
49.0
—
0
23
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
51
1.78
0.95
1.1
2.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
51
1.78
0.95
3.0
4.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
62
1.79
0.95
1.6
1.6
—
—
—
0
0
(4306422)
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
500
0.76
0.88
8.5
8.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
166
0.59
0.85
1.0
1.2
—
—
—
0
0
(44790047)
8
45
1.79
0.84
1.1
1.7
—
—
—
0
0
(44806118)
8
45
1.79
0.84
1.1
1.7
—
—
—
0
0
(44790049)
8
45
1.79
0.84
1.1
1.7
—
—
—
0
0
(44790048)
8
45
1.79
0.84
1.1
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(4027681)
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.1
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
174
1.40
0.78
2.3
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
68
572
1.22
0.77
2.2
2.7
%
17.1
22.1
2.51
61
494
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
93
1062
0.84
0.75
2.0
2.1
mg/l
3.6
3.1
1.00
85
901
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
292
2769
1.15
0.75
14.9
8.1
u/l
91.5
81.1
1.97
282
2575
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
79
678
1.20
0.74
2.2
3.1
e6/l
1.7
1.0
0.63
42
420
(3000330) Specific gravity of Urine by Test strip
14
206
0.67
0.73
3.9
4.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
60
1.68
0.72
1.5
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
493
0.79
0.69
4.3
4.9
%
34.6
32.0
0.65
28
315
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
27
1.86
0.68
1.6
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
55
459
1.23
0.68
1.7
1.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
49
408
1.23
0.63
3.9
4.2
kpa
6.1
5.8
1.00
49
395
(3049717) Cytology report of Urine Cyto stain
17
233
0.72
0.62
2.1
2.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
49
1.64
0.62
1.1
1.3
—
—
—
0
0
(3012544) pH of Venous blood
50
418
1.22
0.62
3.9
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
54
634
0.83
0.60
12.2
29.6
inr
1.2
1.4
—
5
85
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
21
0.00
0.60
0.0
1.1
—
13.1
—
0
7
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
1.0
—
0
10
(40760892) CBC W Ordered Manual Differential panel - Blood
59
686
0.84
0.59
4.8
5.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
35
1.72
0.58
1.0
1.1
—
—
—
0
0
(4094501)
5
86
0.58
0.56
1.4
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
65
1.55
0.56
1.1
1.2
—
2.8
—
0
11
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
37
1.63
0.55
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
126
0.63
0.55
1.1
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
97
874
1.14
0.51
2.4
2.7
e6/l
4.5
3.8
0.37
88
768
(3037467) Urinalysis macro (dipstick) panel - Urine
234
2455
0.90
0.49
4.5
4.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
147
1577
0.90
0.47
2.5
2.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
68
1.48
0.47
1.3
2.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
198
0.75
0.46
2.4
2.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
50
1.41
0.45
2.1
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
50
1.41
0.45
1.9
5.2
mmol/l
6.6
6.5
—
7
40
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
187
1977
0.91
0.45
4.9
3.3
u/l
62.2
56.4
0.33
171
1806
(40768800) Prostate Pathology biopsy report
10
140
0.71
0.44
1.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
53
463
1.16
0.44
1.3
1.3
iu/ml
33.2
41.5
0.27
12
134
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
305
0.81
0.43
1.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
465
0.85
0.42
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.0
—
38.0
—
0
9
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
16
0.00
0.41
0.0
4.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.8
—
32.0
—
0
11
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
59
1.36
0.41
1.1
1.1
—
2.1
—
0
6
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
59
1.36
0.41
1.3
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
17
0.00
0.40
0.0
1.0
—
65.7
—
0
12
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(4211845)
0
17
0.00
0.40
0.0
3.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
74
667
1.13
0.40
2.2
2.6
umol/l
8.3
12.4
9.37
69
615
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
18
226
0.79
0.40
3.9
3.6
mmol/l
25.7
24.8
0.74
18
218
(3037556) Urate [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
1.0
1.2
nmol/l
0.6
0.5
—
5
31
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
69
1.31
0.37
3.4
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
310
0.83
0.37
1.4
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
116
0.68
0.37
1.0
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
433
1.15
0.36
1.2
1.3
u/ml
36.6
11.8
0.49
11
160
(3039000) Anion gap in Blood
14
108
1.31
0.35
5.4
6.4
mmol/l
10.1
11.4
0.83
14
95
(3018572) Chloride [Moles/volume] in Blood
14
108
1.31
0.35
5.4
6.4
mmol/l
103.2
105.7
0.68
14
95
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
433
0.87
0.33
5.3
3.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
90
0.66
0.33
1.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
187
0.80
0.32
1.3
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
165
0.78
0.32
1.1
2.7
g/l
3.7
3.7
—
8
120
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
165
0.78
0.32
1.1
2.7
g/l
8.6
7.4
—
8
124
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
165
0.78
0.32
1.1
2.7
—
—
—
0
0
(3013512) EKG study
112
1195
0.92
0.32
4.9
4.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
52
1.35
0.31
2.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
2.1
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
2.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
2.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
53
1.33
0.31
2.0
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
102
1.28
0.30
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
102
1.28
0.30
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
35
308
1.15
0.29
4.7
3.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
103
1.27
0.28
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
116
0.77
0.27
1.3
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
289
0.86
0.27
1.4
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
66
1.22
0.27
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
78
1.29
0.24
1.3
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
20
171
1.18
0.23
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
145
1392
1.06
0.21
3.2
3.2
ng/l
1311.5
1825.3
1.39
133
1218
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
31
345
0.89
0.21
5.0
3.3
kpa
4.6
4.5
0.13
31
333
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
12
0.00
0.21
0.0
1.1
—
403.4
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
14
166
0.84
0.21
1.3
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
147.5
—
0
13
(3019060) Gas panel - Arterial blood
37
336
1.11
0.20
3.0
4.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
24
271
0.88
0.20
3.4
4.2
%
0.1
0.2
0.20
12
80
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
9.0
—
0
14
(3028707) Methadone [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
34
373
0.90
0.19
2.0
2.4
g/l
0.2
0.2
0.98
34
345
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
41
378
1.09
0.17
2.0
3.2
ng/l
166.8
243.2
1.05
36
343
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
61
1.15
0.17
1.3
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
62
1.13
0.17
1.1
6.7
iu/ml
—
2090.3
—
0
10
(3017181) Myelocytes/100 leukocytes in Blood
28
309
0.90
0.17
3.3
4.1
%
0.6
1.0
0.54
14
104
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
155
1600
0.95
0.17
4.9
4.3
ng/l
38.7
50.2
0.42
133
1262
(3008898) HLA-B27 [Presence]
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
130
1.16
0.16
2.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
84
1.19
0.14
1.7
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
19
208
0.91
0.10
2.8
3.0
%
0.6
0.7
0.59
19
203
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
47
1.06
0.09
1.0
1.6
iu/l
28.7
22.4
—
5
40
(3021440) Promyelocytes/100 leukocytes in Blood
27
288
0.93
0.09
3.4
4.2
%
0.1
0.2
0.09
14
95
(3009542) Hematocrit [Volume Fraction] of Blood
278
2809
0.97
0.08
34.2
19.5
%
37.8
38.4
0.61
180
1697
(3027945) Reticulocytes/100 erythrocytes in Blood
51
531
0.96
0.08
2.0
2.4
%
1.7
1.7
0.05
45
470
(3002179) Metamyelocytes/100 leukocytes in Blood
26
276
0.94
0.07
3.5
4.1
%
0.4
0.5
0.08
12
76
(3037121) Protein [Mass/volume] in Urine
13
143
0.91
0.07
1.7
3.3
g/l
0.2
0.2
—
6
60
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
78
1.03
0.07
1.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
86
1.05
0.07
2.1
3.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
38
396
0.96
0.06
2.2
2.6
e9/l
64.5
66.3
0.11
25
313
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
114
1160
0.98
0.05
2.6
2.2
u/l
331.4
299.8
0.15
109
1079
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
119
0.92
0.04
1.1
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
19
199
0.95
0.03
4.7
5.0
%
2.0
1.6
1.06
19
184
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
201
1.05
0.03
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
37
360
1.03
0.03
1.5
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
182
1.05
0.02
1.2
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
19
198
0.96
0.02
5.2
5.1
%
0.9
0.9
0.33
19
183
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
114
1.05
0.00
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
126
0.95
0.00
4.1
5.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
98
1.02
0.00
12.3
3.7
mg/l
1.7
1.8
—
10
85
(3019230) Fractional oxyhemoglobin in Venous blood
7
72
0.97
0.00
2.4
2.7
%
58.4
61.7
—
7
72
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
2.0
—
82.6
—
0
5
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
91
0.99
0.00
1.1
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.3
—
0.7
—
0
7
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
9.1
—
2056.2
—
0
9
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
76
0.92
0.00
1.3
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
96
0.94
0.00
1.3
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.8
—
3149.6
—
0
8
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
17.9
—
0
9
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
9
0.00
0.00
0.0
12.9
—
6.3
—
0
9
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.3
—
1020.3
—
0
9
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
59
0.85
0.00
1.2
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.3
—
112.5
—
0
8
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
73.7
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
8.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
73
0.96
0.00
2.3
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1673.9
—
0
9
(4146454)
5
53
0.94
0.00
1.2
2.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
8.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
6.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
9.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MESOTHELIOMA – Mesothelioma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).